Humoral and cellular responses to SARS-CoV-2 variants after AstraZeneca/COVISHIELD vaccination in the primary protocol and follow-up

Capão, Artur Silva Vidal; Araújo, Mia Ferreira de; Luis, Fernando Lopez Tort; Oliveira, Any Caroline Alves de; Toledo, Thais Stelzer; Sette, Alessandro; Griffoni, Alba; Siqueira, Marilda; Côrtes, Fernanda Heloise; Garcia, Cristiana Couto.
No convencional en Inglés | ARCA | ID: arc-57929

Documentos relacionados

  1. T Cell Responses to SARS-CoV-2.
  2. COVID-19 vaccine research and development: ethical issues.
  3. Tributaries of the 2023 Nobel Prize in Physiology or Medicine, and lessons learned.
  4. Political polarization may affect attitudes towards vaccination. An analysis based on the European Social Survey data from 23 countries.
  5. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
  6. Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history.
  7. COVID-19 vaccination in pediatric solid organ transplant recipients-Current state and future directions.
  8. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
  9. Reverse Engineering of a Pathogenic Antibody Reveals the Molecular Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia.
  10. Evaluation of local and systemic side effects of Turkovac vaccine in adults.